Altered serotonin receptor expression is associated with depression-related behavior in the R6/1 transgenic mouse model of Huntington's disease.
about
Mood disorders in Huntington's disease: from behavior to cellular and molecular mechanismsMouse models of polyglutamine diseases: review and data table. Part IA Model of Post-Infection Fatigue Is Associated with Increased TNF and 5-HT2A Receptor Expression in MiceElevated paternal glucocorticoid exposure alters the small noncoding RNA profile in sperm and modifies anxiety and depressive phenotypes in the offspring.Effects of deletion of mutant huntingtin in steroidogenic factor 1 neurons on the psychiatric and metabolic phenotype in the BACHD mouse model of Huntington diseaseEnvironmental enrichment and brain repair: harnessing the therapeutic effects of cognitive stimulation and physical activity to enhance experience-dependent plasticitySex-dependent changes in social behaviors in motor pre-symptomatic R6/1 mice.Impulsivity is associated with uric acid: evidence from humans and miceHuntingtin acts non cell-autonomously on hippocampal neurogenesis and controls anxiety-related behaviors in adult mouseDifferential Alteration in Expression of Striatal GABAAR Subunits in Mouse Models of Huntington's DiseaseAltered dopamine and serotonin metabolism in motorically asymptomatic R6/2 miceBeneficial effects of environmental enrichment and food entrainment in the R6/2 mouse model of Huntington's disease.Sexually dimorphic serotonergic dysfunction in a mouse model of Huntington's disease and depression.Effect of enhanced voluntary physical exercise on brain levels of monoamines in Huntington disease miceStandardized environmental enrichment supports enhanced brain plasticity in healthy rats and prevents cognitive impairment in epileptic rats.Is Dysregulation of the HPA-Axis a Core Pathophysiology Mediating Co-Morbid Depression in Neurodegenerative Diseases?Modeling mitochondrial dysfunctions in the brain: from mice to men.Treatment of depressive-like behaviour in Huntington's disease mice by chronic sertraline and exercise.Hippocampal neurogenesis, cognitive deficits and affective disorder in Huntington's diseaseEnvironmental enrichment rescues female-specific hyperactivity of the hypothalamic-pituitary-adrenal axis in a model of Huntington's disease.Impact of neonatal iron deficiency on hippocampal DNA methylation and gene transcription in a porcine biomedical model of cognitive development.Expression of mutant huntingtin in leptin receptor-expressing neurons does not control the metabolic and psychiatric phenotype of the BACHD mouseDissociating the therapeutic effects of environmental enrichment and exercise in a mouse model of anxiety with cognitive impairment.A Tale of Two Maladies? Pathogenesis of Depression with and without the Huntington's Disease Gene Mutation.Positive environmental modification of depressive phenotype and abnormal hypothalamic-pituitary-adrenal axis activity in female C57BL/6J mice during abstinence from chronic ethanol consumptionPatterns of serotonergic antidepressant usage in prodromal Huntington diseaseThe 3rd Schizophrenia International Research Society Conference, 14-18 April 2012, Florence, Italy: summaries of oral sessions.Viral vector mediated expression of mutant huntingtin in the dorsal raphe produces disease-related neuropathology but not depressive-like behaviors in wildtype mice.Stem cell-based therapy for Huntington's disease.RNA-sequencing profiles hippocampal gene expression in a validated model of cancer-induced depression.Huntington's Disease: Pathogenic Mechanisms and Therapeutic Targets.Quercetin improves behavioral deficiencies, restores astrocytes and microglia, and reduces serotonin metabolism in 3-nitropropionic acid-induced rat model of Huntington's Disease.Neuroendocrine Coordination of Mitochondrial Stress Signaling and Proteostasis.Differential effects of early environmental enrichment on emotionality related behaviours in Huntington's disease transgenic mice.Environmental Enrichment as a Positive Behavioral Intervention Across the Lifespan.Novel protective mechanisms of antidepressants against 3-nitropropionic acid induced Huntington's-like symptoms: a comparative study.Neurocardiac dysregulation and neurogenic arrhythmias in a transgenic mouse model of Huntington's disease.Loss of the Sexually Dimorphic Neuro-Inflammatory Response in a Transgenic Mouse Model of Huntington's Disease.Brain Cholesterol Synthesis and Metabolism is Progressively Disturbed in the R6/1 Mouse Model of Huntington's Disease: A Targeted GC-MS/MS Sterol Analysis.Selection of behaviors and segmental coordination during larval locomotion is disrupted by nuclear polyglutamine inclusions in a new Drosophila Huntington's disease-like model.
P2860
Q21131050-ACE561A6-9EDC-489A-B95D-5CCB8935E9E4Q26853025-B105887E-E5C0-405C-9137-E54732FBA487Q27303855-5F0E6C6F-AAD8-4025-8690-B927FE5314D6Q27339409-A684706E-FB37-4396-8C1B-73CB1FBEBE25Q27346849-7584853C-D212-4F77-AD0E-3210A2C8C0F8Q28304384-162EB910-7307-4CDF-BA0C-11C01226A9D9Q30475466-4F6545BE-5174-4A0E-AD81-62F42025A8ACQ30559234-9184DAE0-9B54-40D4-B7C0-74F81FC46117Q31137700-72F183E2-CA13-41BC-824B-FA5EC9F2475AQ33813021-A81BD287-27B6-47F1-A150-AD61E9AF7F2AQ33869789-E4ED75AD-75DE-439D-A1F4-9145B8711ABAQ33935845-C3EA9960-419A-4ACE-954A-4F1538543E88Q33961770-032F7C27-9356-4E6E-A31E-75FEA5499DBCQ34135360-4C83A066-BB36-4F7A-A931-D8EAEC7368D3Q34558891-08D014E0-BDAC-4570-9189-065E262BF9CBQ35158376-86E6CB2E-224C-439E-8051-4A327E55A9FFQ35754400-DC9C70C2-3F93-446C-95DF-A25AA23E4ED1Q36024880-6E9A00C9-7BF9-4150-8AF0-8CB20BAABE0BQ36088666-99EFB7AC-0C6F-4F4F-813B-BA139CB599B9Q36136010-FA593457-9576-4123-A17A-14F36B92908EQ36181276-7F9F4A82-374B-4191-AD7A-4687EF50FE49Q36459384-43B7D6BF-837B-4814-B031-470769AAE2F3Q36915393-E61B90B8-9097-47E1-AF35-A9188AEF47AAQ36993596-5B33F347-C2E4-4B8B-9C1A-1D88BFB5C77DQ37043447-680540A4-F686-4B69-A982-CC6CE39C6B00Q37148863-8BB1FD6C-F83D-4BEB-92F4-5546486D7646Q37425054-BCF99D96-D4EB-42FE-B11D-C54C577BC979Q37696661-025448BB-D878-43A2-BB83-72C23B239847Q38055455-89F4A019-EABD-441E-BF25-A1D8EA5FDED9Q38443525-0BED2ED7-6D46-42B7-8ABD-233069EF16A0Q38663090-9C331E9F-2924-4396-AC22-561FD4F363CBQ39217739-80EDFF92-25DA-419B-B083-3D9E9B1B488DQ39407786-11870190-EA67-4DF0-A3B4-180FE03DB1E3Q42671677-52DB3F93-3DE0-4C0E-8B75-697722E87328Q42711929-2ED8D90F-887D-4DA4-8571-9F51555B1A65Q43122795-0D9E9C1E-12DA-47ED-B449-EC227E98D736Q45289568-1F000D7D-5331-46FC-B71A-FA2D27AAB17AQ45291463-93BA67B7-CAFC-4ADA-9AB3-D1CB6527EC8CQ45291729-13CA2CB5-1DB7-4DBB-9639-34DF670E3B63Q45300572-472FCD4E-75F7-42E5-87E2-09DC1A358E8A
P2860
Altered serotonin receptor expression is associated with depression-related behavior in the R6/1 transgenic mouse model of Huntington's disease.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh-hant
name
Altered serotonin receptor exp ...... model of Huntington's disease.
@en
Altered serotonin receptor exp ...... model of Huntington's disease.
@nl
type
label
Altered serotonin receptor exp ...... model of Huntington's disease.
@en
Altered serotonin receptor exp ...... model of Huntington's disease.
@nl
prefLabel
Altered serotonin receptor exp ...... model of Huntington's disease.
@en
Altered serotonin receptor exp ...... model of Huntington's disease.
@nl
P2093
P2860
P356
P1476
Altered serotonin receptor exp ...... model of Huntington's disease.
@en
P2093
Anthony J Hannan
Michelle S Zajac
Monique L Howard
Terence Y C Pang
P2860
P304
P356
10.1093/HMG/DDN385
P577
2008-11-13T00:00:00Z